Stay updated on Psilocybin for Depression in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.

Latest updates to the Psilocybin for Depression in Early Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a small backend or metadata update to the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision/version indicator has been updated from **v3.5.2** to **v3.5.3**, reflecting a site/software update rather than any change to the trial information.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded new Study Contact Backup details for Albert Garcia-Romeu, PhD and Ian Geithner, MPS (emails and phone numbers) and Johns Hopkins Center for Psychedelic and Consciousness Research; removed Hillary Jackson and related contact information.SummaryDifference2%

- Check69 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed. This update appears to be an internal version change and does not alter study content or functionality visible on the page.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 was introduced on the page. The Online study screener, Johns Hopkins University sponsor attribution, the Helpful Links Provided by section, and the previous Revision: v3.4.1 were removed.SummaryDifference0.2%

Stay in the know with updates to Psilocybin for Depression in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.